The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10969 malaria professionals are enjoying the free benefits of MalariaWorld today

opisthorchis viverrini

Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial

January 26, 2011 - 09:47 -- Patrick Sampao
Phonepasong Soukhathammavong, Peter Odermatt, Jennifer Keiser, et al.
The Lancet Infectious Diseases, Volume 11, Issue 2, February 2011, Pages 110-118

We did a randomised open-label trial between February and April, 2010, in the Saysetha district, Attapeu Province, Laos. Eligible patients were school children aged 10–15 years who had O viverrini infections.

Subscribe to RSS - opisthorchis viverrini